Skip to content

Clinical trials

Phase 1 Mucopolysaccharidosis II trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis II Phase: Phase 1 Country / region: United States Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20141
20151
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Joanne Kurtzberg, MD2
ArmaGen, Inc1
Duke University1
Homology Medicines, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II5
Metabolism, Inborn Errors2
Mucopolysaccharidosis I2
Sudden Infant Death2
Adrenoleukodystrophy1
Anemia, Aplastic1
Anemia, Diamond-Blackfan1
Brain Diseases, Metabolic, Inborn1
Hematologic Neoplasms1
Hemoglobinopathies1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.